Home > Healthcare > Analytical Instruments > Immunoassay > Immunoassay Market

Immunoassay Market Trends

Report ID: GMI8041
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Immunoassay Market Trends

The rising prevalence of chronic conditions, such as diabetes, cardiovascular diseases, and autoimmune disorders will play an ideal role for the market growth. They are being used to detect biomarkers for enabling early diagnosis and monitoring. With chronic diseases continuing to surge, immunoassays are evolving to provide more precise and rapid testing, aiding in effective disease management.

Researchers and healthcare providers are also focusing on developing new immunoassay techniques as they are emerging more essential in tailoring personalized treatments and improving patient outcomes as chronic conditions are expected to rise globally. For instance, in 2023, the Centers for Disease Control and Prevention (CDC) reported that six in ten individuals in the U.S. have at least one chronic disease. To that end, immunoassays have grown vital for diagnosis and management while detecting specific biomarkers for aiding in effective treatment strategies.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Immunoassay Market size was valued at over USD 31.3 billion in 2023 and is estimated to expand at 5.3% CAGR from 2024 to 2032 due to the rise in partnerships and collaborations focused on innovative diagnostics and therapeutic solutions.

The reagents & kits segment in the market is poised to expand at 5.1% CAGR from 2024 to 2032, fueled by the rising usage of immunoassay reagents & kits as integral components of immunoassay procedures to facilitate the detection of specific biomarkers.

North America immunoassay market size is expected to record 5% CAGR through 2032 driven by the growing demand for innovative diagnostic solutions.

Abbott Laboratories, Agilent Technologies, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Luminex Corporation, PerkinElmer, Inc., QIAGEN, Sysmex Corporation, and Thermo Fisher Scientific Inc.